Marsh & McLennan Companies (NYSE:MRSH – Get Free Report) had its target price dropped by analysts at Barclays from $209.00 to $206.00 in a research note issued on Wednesday,Benzinga reports. The brokerage presently has an “overweight” rating on the financial services provider’s stock. Barclays‘s price target points to a potential upside of 18.96% from the stock’s current price.
A number of other analysts have also recently commented on MRSH. Keefe, Bruyette & Woods dropped their target price on shares of Marsh & McLennan Companies from $206.00 to $200.00 and set a “market perform” rating on the stock in a report on Tuesday. Evercore lowered their price target on shares of Marsh & McLennan Companies from $237.00 to $236.00 and set an “outperform” rating for the company in a research report on Wednesday, January 7th. Mizuho reissued a “neutral” rating and set a $199.00 price objective (down from $213.00) on shares of Marsh & McLennan Companies in a research note on Friday, February 27th. JPMorgan Chase & Co. decreased their target price on shares of Marsh & McLennan Companies from $242.00 to $226.00 and set an “overweight” rating for the company in a research note on Wednesday, January 7th. Finally, Morgan Stanley lowered their target price on shares of Marsh & McLennan Companies from $195.00 to $190.00 and set an “equal weight” rating for the company in a report on Monday. One analyst has rated the stock with a Strong Buy rating, five have given a Buy rating, eleven have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of $208.38.
Read Our Latest Report on MRSH
Marsh & McLennan Companies Stock Performance
Marsh & McLennan Companies (NYSE:MRSH – Get Free Report) last released its quarterly earnings results on Thursday, January 29th. The financial services provider reported $2.12 earnings per share for the quarter, beating the consensus estimate of $1.97 by $0.15. The company had revenue of $6.60 billion for the quarter, compared to analyst estimates of $6.52 billion. Marsh & McLennan Companies had a return on equity of 31.60% and a net margin of 15.42%.The firm’s revenue was up 8.7% on a year-over-year basis. During the same period in the previous year, the company posted $1.87 earnings per share. Sell-side analysts forecast that Marsh & McLennan Companies will post 9.61 earnings per share for the current year.
Insiders Place Their Bets
In other Marsh & McLennan Companies news, CEO John Q. Doyle sold 16,655 shares of the company’s stock in a transaction dated Wednesday, March 4th. The shares were sold at an average price of $183.30, for a total transaction of $3,052,861.50. Following the transaction, the chief executive officer owned 116,811 shares in the company, valued at approximately $21,411,456.30. This represents a 12.48% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 0.35% of the company’s stock.
Institutional Inflows and Outflows
Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Numerai GP LLC raised its holdings in Marsh & McLennan Companies by 966.2% in the 3rd quarter. Numerai GP LLC now owns 37,220 shares of the financial services provider’s stock worth $7,501,000 after purchasing an additional 33,729 shares during the period. Rockland Trust Co. grew its holdings in Marsh & McLennan Companies by 801.6% during the third quarter. Rockland Trust Co. now owns 12,073 shares of the financial services provider’s stock valued at $2,433,000 after purchasing an additional 10,734 shares during the period. Barclays PLC increased its position in Marsh & McLennan Companies by 41.7% in the third quarter. Barclays PLC now owns 2,202,372 shares of the financial services provider’s stock worth $443,844,000 after buying an additional 647,987 shares in the last quarter. Navera Investment Management Ltd. raised its stake in shares of Marsh & McLennan Companies by 7.0% in the third quarter. Navera Investment Management Ltd. now owns 1,623,960 shares of the financial services provider’s stock worth $327,303,000 after buying an additional 105,954 shares during the period. Finally, Bridges Investment Management Inc. lifted its position in shares of Marsh & McLennan Companies by 4.4% during the 3rd quarter. Bridges Investment Management Inc. now owns 76,196 shares of the financial services provider’s stock valued at $15,356,000 after buying an additional 3,177 shares in the last quarter. Institutional investors own 87.99% of the company’s stock.
Marsh & McLennan Companies News Roundup
Here are the key news stories impacting Marsh & McLennan Companies this week:
- Positive Sentiment: Barclays maintained its buy/overweight rating on MRSH even after a small cut to its price target, signaling continued conviction in the name. Barclays Sticks to Their Buy Rating for Marsh & McLennan Companies (MRSH)
- Positive Sentiment: JPMorgan cut its price target (from $226 to $206) but left an “overweight” rating — the balance of a lower PT with an overweight call can support the stock if results / guidance remain solid. Benzinga Coverage
- Positive Sentiment: Zacks previews upcoming earnings and flags MRSH as positioned for a likely beat, which is supportive if the company repeats its recent outperformance. Marsh (MRSH) Earnings Expected to Grow: Should You Buy?
- Positive Sentiment: Marsh expanded its U.S. regional footprint by acquiring Seitz Insurance Agency in Montana — a small tuck‑in that can boost middle‑market reach and cross‑selling. Marsh Expands Montana Reach With Seitz Insurance Agency Acquisition
- Neutral Sentiment: Morgan Stanley reiterated a Hold on MRSH — adds to the mixed broker view and keeps consensus centered around “hold.” Morgan Stanley Keeps Their Hold Rating on Marsh & McLennan Companies (MRSH)
- Neutral Sentiment: Options activity shows traders are positioning for a big move — indicates higher near‑term volatility but not directional conviction. Are Options Traders Betting on a Big Move in Marsh Stock?
- Neutral Sentiment: Market / PR items (NYSE summit mention, industry writeups) are background noise for MRSH and unlikely to move the stock materially on their own. NYSE Content Update: Fourth Annual NYSE Sustainability Leaders Summit to Commence
- Neutral Sentiment: Coverage pieces highlighting the company’s advisory strength and value creation are supportive over the long term but are not immediate catalysts. Marsh McLennan Business Creates Value Through Expert Guidance
- Negative Sentiment: Wells Fargo lowered its price target sharply (from $203 to $178) and moved to an “equal weight” rating — the cut and downgrade increase near‑term downside pressure and likely contributed to the stock falling. Benzinga Coverage
Marsh & McLennan Companies Company Profile
Marsh & McLennan Companies (NYSE: MMC) is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.
The firm operates through several well-known subsidiaries and business units that specialize in distinct services.
Further Reading
Receive News & Ratings for Marsh & McLennan Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marsh & McLennan Companies and related companies with MarketBeat.com's FREE daily email newsletter.
